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Nonsustained ventricular tachycardia, although usually 
asymptomatic, is associated with a high risk of sudden 
cardiac death in patients with depressed left ventricular 
function. To test the vulnerability of such patients to 
symptomatic and potentially life-threatening arrhyth-
mias, complete electrophysiologic studies were per-
formed in 58 patients with clinically documented non-
sustained ventricular tachycardia (2:three complexes but 
<15 seconds of self-terminating ventricular tachycardia 
by 24 hour ambulatory electrocardiographic [Holter] or 
telemetric monitoring) and abnormal left ventricular 
function (ejection fraction <50% by radionuclide an-
giography). All patients had nonsustained ventricular 
tachycardia in the absence of antiarrhythmic drugs, acute 
ischemia, long QT syndrome, recent infarction or elec-
trolyte abnormalities. The stimulation protocol for each 
patient included the introduction of single, double and 
triple ventricular extrastimuli at three cycle lengths (si-
The prognosis for patients with non sustained ventricular 
tachycardia varies with the clinical setting in which the 
arrhythmia occurs (1-6). In patients without organic heart 
disease, nonsustained ventricular tachycardia has been as-
sociated with a normal life expectancy (1,2). However, 
several large observational studies (3-5), performed over 
the past several years in patients who have had an acute 
myocardial infarction, have shown that this same arrhyth-
mia, defined as even a single triplet on a baseline 24 hour 
Holter recording, is associated with a 30 to 50% 2 year 
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nus, 600 and 450 ms) and two right ventricular sites 
(apex and outflow tract). A sustained ventricular tachy-
arrhythmia was induced in 23 patients (40%) and a 
nonsustained ventricular tachycardia in 14 patients (24%). 
Induction of sustained tachycardia correlated with the 
presence of akinesia or aneurysm, or both, by radio-
nuclide angiography, but not with ejection fraction or 
presence or absence of coronary artery disease. 
These results indicate that: 1) patients with clinical 
nonsustained ventricular tachycardia and chronic left 
ventricular dysfunction have a high incidence of induc-
ible sustained ventricular tachycardia or ventricular 
fibrillation; and 2) electrophysiologic testing may allow 
further substratification of risk of sudden cardiac death 
in high risk patients with nonsustained ventricular 
tachycardia. 
(J Am Coli CardioI1985;6:31-9) 
mortality rate. A similarly high risk of sudden death has 
been demonstrated for patients with nonsustained ventricular 
tachycardia and chronic left ventricular dysfunction (6). The 
purpose of this study was to use programmed ventricular 
stimulation to test the vulnerability of patients with chron-
ically poor left ventricular function and clinically docu-
mented nonsustained ventricular tachycardia to sustained 
and potentially life-threatening ventricular tachyarrhythmias. 
Methods 
Definitions. To establish inclusion criteria for this study, 
the following definitions were used: 1) abnormal left ven-
tricular function was defined as an ejection fraction less than 
50% by radionuclide angiography using either a first pass 
or gated technique; and 2) nonsustained ventricular tachy-
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cardia was defined as three or more complexes but less 
than 15 seconds of self-terminating ventricular tachycardia 
by 24 hour ambulatory electrocardiographic [Holter] or te-
lemetric monitoring. It was required that the arrhythmia 
occur in the absence of antiarrhythmic drugs, acute isch-
emia, recent «3 months) myocardial infarction, long QT 
syndrome or electrolyte abnormalities. Patients with prior 
documented cardiac arrest or sustained ventricular tachy-
cardia, even if present only during treatment with antiar-
rhythmic medications, were excluded. Patients were not 
excluded for neurologic symptorris unless these were as-
sociated with a documented sustained arrhythmia or cardiac 
arrest. 
Study patients. The study group consisted of 58 pa-
tients. There were 47 men and 11 women ranging in age 
from 28 to 78 years (mean 61). Cardiac catheterization was 
performed in 21 patients. Clinical diagnoses included coro-
nary artery disease in 28 patients (confirmed by coronary 
angiography in II patients or by the presence of a docu-
mented myocardial infarction or a history of classic angina 
in 17 patients), congestive cardiomyopathy in 22, valvular 
heart disease in 6 and combined valvular and coronary artery 
disease in 2. Thirty-six (62%) of the patients had no symp-
toms associated with their arrhythmia, 13 had transient pal-
pitation, 5 had dizziness, 3 had syncope and I had transient 
chest pain. Mean ejection fraction for the group was 27% 
(range 8 to 48) and mean cardiac index calculated from the 
radionuclide angiograms was 2.6 liters/min per m2 (range 
1.4 to 5.2). Sixteen of the 28 patients with coronary artery 
disease had at least one akinetic or dyskinetic ventricular 
segment by radionuclide angiography. Before electrophys-
iologic testing, 48 (82%) of the 58 patients had been treated 
empirically with one to five antiarrhythmic medications, 
including type IA agents in 34 patients, phenytoin in 10 and 
experimental drugs in 4. 
Arrhythmia documentation. The presence of nons us-
tained ventricular tachycardia, while the patients were not 
receiving any antiarrhythmic medications, was documented 
by complete 24 hour Holter monitor recordings in 45 patients 
(78%) and by telemetric monitoring in the remaining 13 
patients. Of the patients with full Holter monitor data, 50% 
had 1 to 10 occurrences of nonsustained ventricular tachy-
cardia, 23% had between 10 and 100 occurrences and 27% 
had more than 100 occurrences. The mean number of com-
plexes in the longest run of non sustained ventricular tachy-
cardia was 6 (range 3 to 25). The mean upper rate of the 
tachycardia was 151 beats/min (range 100 to 200). Mean 
ventricular premature complex frequency was 504/h with a 
wide range of between 1 to 2,162. Thirty-five (81%) of the 
patients had more than 100 ventricular premature com-
plexes/h and 41 (96%) had couplets. 
Electrophysiologic testing. Programmed ventricular 
stimulation was performed in the postabsorptive state after 
informed written consent was obtained and antiarrhythmic 
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medications had been discontinued for at least five half-
lives. Three multipOlar electrode catheters were inserted 
percutaneously or by cutdown and positioned under fluo-
roscopic guidance in the high right atrium, at the A V junc-
tion in the His bundle position and at the right ventricular 
apex. The right ventricular apical catheter was later repo-
sitioned in the right ventricular outflow tract in those patients 
in whom sustained arrhythmia was not induced at the right 
ventricular apex. Stimulation was performed using a cus-
tom-designed programmable stimulator with optically iso-
lated constant-current sources (Bloom Associates, Ltd.) set 
to produce rectangular pulses 1 ms in duration and twice 
diastolic threshold. Threshold was always less than 2 rnA. 
Three electrocardiographic leads (I, II and V,) were re-
corded along with bipolar intracardiac electrograms from 
each site filtered at 30 to 500 Hz. All recordings were 
simultaneously displayed on a multichannel oscilloscope 
(Electronics for Medicine VR 16) and recorded on magnetic 
tape (Honeywell 5600) for subsequent retrieval on photo-
graphic paper. Real-time records were also obtained with 
an inkjet recorder (Mingograph, Siemens Elema) at paper 
speeds of 100 to 200 ri:un/s. 
In each case the stimulation protocol included the intro-
duction of single, double and triple ventricular extrastimuli 
during sinus rhythm and two paced ventricular cycle lengths 
(S,S,) of 600 and 450 ms at both the right ventricular apex 
and right ventricular outflow tract. Ventricular extrastimuli 
were introduced beginning in late diastole at the right ven-
tricular apex first and were moved progressively earlier in 
10 to 20 ms decrements until ventricular refractoriness was 
achieved. If a single extrastimulus (S2) did not result in 
initiation of a sustained tachycardia, a second extrastimulus 
(S3) was added. The S,S2 interval was reset to 50 to 100 
ms greater than the ventricular effective refractory period 
and the S2S3 interval was programmed to equal the S, S2 
interval. The S2S3 interval was progressively decremented 
by 10 to 20 ms until S3 became refractory, at which time 
S2 was decreased by the same amount until S3 again evoked 
a response. This sequence was continued until S2 was again 
refractory or until sustained tachycardia was initiated. If 
double extrastimuli failed to evoke a sustained arrhythmia, 
then a third extrastimulus (S4) was added and the protocol 
was repeated as just described. 
If stimulation at the right ventricular apex did not result 
in a sustained tachycardia, the entire protocol was repeated 
at the right ventricular outflow tract. In no patient was iso-
proterenol infusion or left ventricular stimulation utilized. 
The stimulation sequence was prematurely terminated only 
for the initiation of a sustained ventricular tachyarrhythmia. 
Three categories of response to ventricular stimulation 
were defined: 1) An arrhythmia was considered to be not 
inducible if there were fewer than six repetitive responses 
to programmed stimulation. 2) Nonsustained ventricular 
tachyarrhythmia was defined as six or more complexes but 
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less than 15 seconds of self-terminating monomorphic or 
polymorphic ventricular tachycardia or ventricular fibrilla-
tion. 3) Sustained ventricular tachyarrhythmia was defined 
as at least 15 seconds of inducible monomorphic or poly-
morphic ventricular tachycardia or ventricular fibrillation or 
a tachycardia requiring cardioversion in less than 15 seconds 
as a result of hemodynamic collapse. 
Statistical analysis. Comparisons among the three in-
duced arrhythmia subsets were made using standard statis-
tical techniques, including R x C contingency tables and 
Fisher's exact test for dichotomous variables and analysis 
Table I. Electrophysiologic Data in 37 Patients 
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of variance for continuous variables; p values of less than 
0.05 were accepted as significant. Because of the wide var-
iability in premature ventricular complex frequency and 
number of occurrences of ventricular tachycardia by Holter 
monitoring, these frequencies were converted to their nat-
ural logarithm before analysis. 
Results 
Induced arrhythmias (Table 1). A sustained ventric-
ular tachyarrhythmia was induced in 23 patients (40%) 
Case No. Arrhythmia Induction Mode* Cycle Length (ms) Configuration Termination Mode* 
A. Patients With Induced Sustained Ventricular Arrhythmias 
VT RVA 450 T 340 RBBB/sup axis RVA 300 B 
2 VT RVOT 600 T 230 RBBB/RAD Cx 
3 VT RVA 450 T 2XO RBBB/RAD RVA 250 B 
4 VT RVOT 600 D 240 RBBB/RAD Cx 
5 VT RVOT 450 D 220 LBBB/LAD Cx 
6 VT RVA 600 T 310 RBBB/LAD RVA 230 B 
7 VT RVA 600 T no RBBB/RAD Cx 
X VT RVOT 450 D 240 LBBB/LAD Cx 
9 VT RVOT NSR T 240 LBBB/LAD Cx 
10 VT RVOT 450 T 210 LBBB/LAD Cx 
II VFI RVA 600 D 160 Cx 
12 YFI RVA 600 D 190 Cx 
13 VT RVOT NSR T 240 RBBB/RAD RVA 200 B 
14 VT RVA 450 T 250 RBBB/sup axis RVA 200 B 
15 VF RVOT 600 T Cx 
16 VT RVOT 600 T 250 LBBB/LAD Cx 
17 VF RVA NSR T Spontaneous 
18 VF RVA 450 D Cx 
19 VT RVA 600 D 260 LBBB/LAD RVA 220 B 
20 VFI RVA450T 150 Cx 
21 VF RVA 450 T Cx 
22 VF RVA 600 D Cx 
23 VT RVA 450 D 230 LBBB/normal axis ex 
B. Patients With Induced Nonsustained Ventricular Arrhythmias 
24 RVA 600 D IXO to 330 P 15t 
25 RVA 600 0 250 to 2XO P 14 
26 RVA450T 170 to 220 P <) 
27 RVA 600 D 180 to 2XO P 39 
28 RVA 450 D 250 RBBB/sup axis 12 
29 RVOT NSR T 270 to 400 P 17 
30 RVA 600 D 160 to 190 P 46 
31 RVOT 450 T 200 to 220 P 36 
32 RVA 600 D 220 to 300 P 15 
33 RVA 450 T 320 RBBB/sup axis 20 
34 RVA 450 T 160 to 230 P II 
35 RVOT 4500 140 to 180 P 40 
36 RVOT 600 T 200 to 260 P II 
37 RVA 450 T 160 to 180 P 29 
*This term describes the stimulation site. the paced cycle length (ms) and the stimulation technique. tNumber of complexes. B = burst; Cx = 
cardioversion/defibrillation; D = double extrastimuli; LAD = left axis deviation; LBBB = left bundle branch block; NSR = normal sinus rhythm; P 
= polymorphic; RAD = right axis deviation; RBBB = right bundle branch block; RVA = right ventricular apex; RVOT = right ventricular outflow 
tract; sup = superior; T = triple extrastimuli; VF = ventricular fibrillation; VFI = ventricular flutter; VT = ventricular tachycardia. 
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-Figure 1. Holter monitor tracing from a patient with inducible 
sustained ventricular tachycardia. This two lead strip shows the 
longest episode of nonsustained ventricular tachycardia in this 
patient, lasting five complexes at a rate of 125 to 150 beats/min 
and polymorphic in nature. The patient had ischemic heart disease 
and an ejection fraction of 17%. 
(Table IA). Typical Holter monitor strips and intracardiac 
recordings on one such patient are shown in Figures I and 
2. Ventricular tachycardia with a sustained uniform config-
uration was induced in IS patients and ventricular flutter or 
fibrillation in 8 patients. Double ventricular extrastimuli 
induced the arrhythmia in 9 patients and triple ventricular 
extrastimuli in 14 patients. The mean cycle length for all 
tachycardias excluding ventricular fibrillation was 235 ms 
(range ISO to 340). Cardioversion was required for termi-
nation of the arrhythmia in 16 patients. Burst pacing was 
effective for termination in six patients, and in one patient 
the tachycardia terminated spontaneously. There was no 
consistent correlation in rate or configuration between the 
spontaneous nonsustained ventricular tachycardia and the 
induced sustained tachyarrhythmia in these patients. 
Nonsustained ventricular tachycardia was induced in 14 
patients (Table IB). Figures 3 and 4 show typical Holter 
monitor and intracardiac recordings from one of these pa-
tients. The tachycardia was polymorphic in IS patients and 
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uniform in configuration in only 2 patients. Double ven-
tricular extrastimuli initiated the tachycardia in seven pa-
tients and triple ventricular extrastimuli in the remaining 
seven patients. Individual episodes ranged in duration from 
9 to 46 complexes (mean 22). The cycle lengths of each 
tachycardia, denoted as the shortest and longest RR inter-
vals, varied widely between 160 and 330 ms. By definition, 
the tachycardias terminated spontaneously in all cases. As 
in the patients with inducible sustained ventricular tachy-
cardia and as typified by a comparison of Figures 3 and 4, 
there was no consistent correlation in tate or configuration 
between the spontaneous and induced nonsustained ven-
tricular tachycardias. 
No arrhythmia was inducible in 21 patients despite com-
pletion of the full stimulation protocol at both right ven-
tricular sites (Fig. 5 and 6). 
Correlation between clinical data and induced ar-
rhythmias (Table 2). To determine whether the induction 
of a specific arrhythmia could be predicted from available 
clinical data, baseline clinical information was compared in 
the three induced arrhythmia subsets using standard contin-
gency table analysis and analysis of variance techniques as 
indicated. There was no significant difference in age, sex, 
sytnptoms (including evidence of syncope), prior drug usage, 
ejection fraction or presence or absence of coronary artery 
disease in the three groups. Similarly, no Holter recording 
abnormality allowed separation of the groups. However, the 
presence of an akinetic or aneurysmal segment, or both, by 
radionuclide angiography was significantly greater in pa-
tients in whom a sustained ventricular tachyarrhythmia was 
initiated as compared with the two other groups (sensitivity 
Figure 2. Induction and termination of 
sustained ventricular tachycardia (same 
patient as in Fig. 1). The top and bottom 
panels are both organized as electrocar-
diographic leads I, II and VI and intra-
cardiac electrograms from the high right 
atrium (HRA), His bundle (HBE) and right 
ventricular apex (RVA) and 100 ms time 
lines (T). With triple ventricular extra-
stimuli (S2,S3 and S4) during a paced cycle 
length of 450 ms, ventricular tachycardia 
with a sustained uniform configuration was 
induced (top panel). The tachycardia had 
a cycle length (CL) of 280 ms. The ar-
rhythmia was consistently terminated by 
burst pacing (arrows) at a cycle length 
of 250 ms (bottom panel). 
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-l<'igure 3. Holter monitor tracing from a patient with inducible 
non sustained ventricular tachycardia, This strip shows the longest 
run of nonsustained ventricular tachycardia in this patient, who 
had ischemic heart disease and an ejection fraction of 17%. The 
tachycardia was uniform in configuration at a rate of 136 beats/min. 
48%, specificity 86%), The positive predictive value for 
akinesia or aneurysm, that is, the likelihood that a patient 
with such contraction abnormalities would have a sustained 
ventricular tachyarrhythmia induced, was 69%, Patients 
without an akinetic or aneurysmal segment, however, still 
had a 29% chance of having an inducible sustained arrhyth-
mia, Finally, patients with inducible nonsustained ventric-
ular tachycardia had significantly less contraction abnor-
mality than those in the other two groups. 
Discussion 
Previous studies. This study demonstrates that sus-
tained ventricular tachyarrhythmias can be induced in a large 
percent of patients with clinical episodes of nonsustained 
ventricular tachycardia and poor left ventricular function. 
Studies by Gomes et al. (7) and Buxton et al. (8) have 
described the results of e1ectrophysiologic testing in a dif-
ferent group of patients with high grade ventricular ectopic 
activity or nonsustained ventricular tachycardia without prior 
substratification by ventricular function abnormalities. Both 
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Figure 5. Holter monitor tracing from a patient with no inducible 
arrhythmia. This tracing shows the longest run of non sustained 
ventricular tachycardia in this patient. The tachycardia is six com-
plexes in duration at a rate of 166 beats/min and is uniform in 
configuration. The patient had congestive cardiomyopathy and an 
ejection fraction of 14%. 
studies found that a subset of their population with an ab-
normal ejection fraction had an increased incidence of in-
ducible sustained ventricular tachyarrhythmias, In the study 
by Gomes et al. (7), 20 patients had inducible arrhythmias, 
including sustained ventricular tachycardia in 8, ventricular 
fibrillation in 5 and non sustained ventricular tachycardia in 
7. Seventeen of these patients had an ejection fraction of 
40% or less, In the study by Buxton et al. (8), 15 patients 
had inducible sustained ventricular tachycardia, 9 of whom 
had an ejection fraction of 40% or less. In our study, only 
those patients with nonsustained ventricular tachycardia in 
the setting of depressed ventricular function were considered 
for electrophysiologic testing, We chose this group for eval-
uation because previous studies (3-6) have shown, both for 
acute and chronic organic heart disease, that such patients 
are at high risk for sudden cardiac death. In contrast, patients 
with nonsustained ventricular tachycardia and normal ven-
tricular function have a normal or near normal life expectancy, 
In an analysis of 430 patients after acute myocardial 
infarction, for example, Bigger et al. (5) found triplets or 
Figure 4. Induction of non sustained 
ventriculartachycardia (same patient 
as in Fig. 3). The top and bottom 
panels are arranged as electrocar-
diographic leads I, II and V I and in-
tracardiac recordings from the His 
bundle (HBE) and right ventricular 
apex (RVA) in the top panel and 
right ventricular outflow tract (RVOT) 
in the bottom panel and lOOms time 
lines (T). During pacing from either 
site at a cycle length of 450 ms, non-
sustained ventricular tachycardia was 
induced with triple ventricular ex-
trastimuli (S2,S, and S4), 
I ' ,I I! ~. I ,\ 
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Figure 6. Electrophysiologic testing with no inducible arrhythmia 
(same patient as in Fig. 5). The records are organized as in Figure 
4. No arrhythmia was inducible from either site in this patient with 
any pacing method including triple ventricular extrastimuli (S2,S3 
and S4) at a paced cycle length of 450 ms. 
longer runs of ectopic activity by Holter monitoring in 50 
patients (11.6%). These patients subsequently had a 38% 1 
year and a 54% 3 year sudden death mortality rate. In 37 
patients with chronic organic heart disease and nonsustained 
ventricular tachycardia by Holter monitor recording, Fol-
lansbee et al. (6) found a 47% incidence of sudden death 
JACC Vol. 6. No. I 
July 1985:31-9 
during a I year follow-up period in patients with congestive 
heart failure, as opposed to a 6% mortality rate in patients 
without heart failure. Because the primary event for the vast 
majority of patients who die suddenly is sustained ventric-
ular tachyarrhythmia, electrophysiologic testing with pro-
grammed ventricular stimulation as performed here may 
allow further substratification of risk in such high risk pa-
tients. A similar approach was used by Richards et al. (9) 
in studying patients after acute myocardial infarction. 
It is of interest that the mean cycle length of induced 
ventricular tachycardia in our patients was 235 ms, which 
was rapid enough to account for hemodynamic collapse and 
require cardioversion for termination of the arrhythmia in 
16 (70%) of the 23 patients in the subgroup with sustained 
tachyarrhythmia. This is consistent with clinical data from 
other studies on resuscitated patients, such as the Seattle 
Heart Watch (10,11), in which less than 10% of patients 
have a hemodynamically tolerated sustained ventricular 
tachycardia at the time of arrival of a rescue squad. 
Electrophysiologic considerations. The stimulation 
protocol used in this study is our standard laboratory pro-
tocol for patients with ventricular tachyarrhythmias and was 
entirely consistent from patient to patient. No patient was 
studied using currents greater than twice diastolic threshold. 
Left ventricular stimulation and isoproterenol infusion were 
specifically avoided because they could not be uniformly 
applied to the entire patient group. The use of a second 
right ventricular site and triple ventricular extrastimuli have 
been a routine part of our laboratory protocol for several 
years in patients with documented or suspected sustained 
ventricular tachyarrhythmias. Such methods clearly increase 
the sensitivity of electrophysiologic testing; whether spec-
ificity is significantly altered remains a debated issue (12-14). 
Table 2. Correlation Between Clinical Data and Induced Arrhythmias 
Sustained Nonsustained 
Ventricular Ventricular 
Tachyarrhythmias Tachycardia Noninducible 
No. of patients 23 14 21 
Age (yr) (range) 62 (28 to 78) 61 (42 to 78) 61 (43 to 75) 
Sex (M/F) 20/3 1212 15/6 
EF (%) (range) 25 (10 to 48) 31 (17 to 45) 25 (7 to 49) 
Syncope (no. of patients [%)) 1(4%) 0(0%) 2 (10%) 
CAD (no. of patients [%)) 15 (65%) 5 (36%) 10 (48%) 
Akinesia/aneurysm (no. of II (48%)*t 0(0%)* 5 (24%) 
patients [%)) 
Holter monitor data 
VT occurrences (range) 7 (I to 490) 23 (I to 828) 8 (I to 270) 
Longest run (range) 6 (3 to 31) 10 (3 to 42) 9 (3 to 38) 
Upper rate (range) 155 (105 to 200) 145 (120 to 190) 151 (100 to 210) 
VPCs/h (range) 247 (I to 2,162) 270 (27 to 1,698) 130 (3 to 847) 
Couplets (no. of patients [%]) 22 (90%) 13 (93%) 21 (100%) 
*p = 0.006 different from nonsustained ventricular tachycardia; tp = 0.01 different from the other two 
groups; tp = 0.02 different from the other two groups. CAD = coronary artery disease; EF = ejection 
fraction; VPCs = ventricular premature complexes; VT = ventricular tachycardia. 
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Brugada et aL (13) showed that in some patients without 
clinically documented ventricular arrhythmias, such ar-
rhythmias could still be induced in the electrophysiology 
laboratory, especially with aggressive stimulation protocols 
including three and four extrastimuli, However, using the 
same protocol as in our study, the most common arrhythmia 
induced by Brugada and coworkers was polymorphic non-
sustained ventricular tachycardia lasting less than 10 com-
plexes, Ventricular fibrillation was rarely induced and mono-
morphic sustained ventricular tachycardia was never induced, 
Moreover, the study included 17 patients with moderate to 
severe organic heart disease in whom a predisposition to 
ventricular arrhythmias would not be unexpected, There-
fore, the induction in 31 % of our patients of monomorphic 
sustained ventricular tachycardia is unlikely to be artifac-
tuaL In addition, among the 14 patients in our study with 
induction of polymorphic non sustained ventricular tachy-
cardia, the arrhythmia was initiated by double ventricular 
extrastimuli in 50% and had a duration significantly greater 
than the apparently artifactual responses reported by Bru-
gada et ai, (13). Still, the specificity of induced polymorphic 
non sustained ventricular tachycardia in our patient group 
will need to be established by further studies and long-term 
follow-up data. 
Correlations with clinical data. Significantly, the 
subgroups with induced arrhythmia could not have been 
predicted from any Holter monitor criteria including number 
of occurrences of ventricular tachycardia, rate, longest run, 
presence of other degrees of complexity or ventricular pre-
mature complex frequency. This is in agreement with prior 
epidemiologic data from Bigger et aL (5) in patients with 
nonsustained ventricular tachycardia after acute infarction, 
which showed no correlation between the number of epi-
sodes of non sustained ventricular tachycardia or the length 
of the tachycardia runs and mortality in a year or more of 
follow-up study. / There was also no relation between the 
severity of depression of ejection fraction or the presence 
or absence of coronary artery disease and induced arrhythmia. 
However, a correlation was found between the presence 
of a severe contraction abnormality, as assessed by radio-
nuclide angiography, namely, akinesia or aneurysm, or both, 
and the ability to induce a sustained tachyarrhythmia. Eleven 
(69%) of the 16 patients with an akinetic or aneurysmal 
segment, or both, had an inducible sustained arrhythmia as 
compared with 29% without such abnormality. These data 
suggest that the presence of scar is a more important de-
terminant of the ability to sustain a life-threatening tachy-
arrhythmia than is ischemia or abnormal ventricular func-
tion. A great deal of experimental and clinical data support 
such a contention (15-19). The vast majority of patients 
previously reported to have sustained ventricular tachycardia 
have had a ventricular aneurysm anatomically. Even in pa-
tients with ventricular tachycardia after repair of tetralogy 
of Fallot who are without ischemic heart disease, ventricular 
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tachycardia appears to originate in postoperative scar re-
gardless of the degree of right ventricular dysfunction (20). 
Moreover, several investigators (21-23) have demonstrated, 
both in animals and in human beings, that scarred segments 
and aneurysms contain fragmented electrograms that may 
well be markers for slow conduction, one of the specific 
requirements for sustained reentry. Using electrode catheter 
techniques, Josephson et aL (24) demonstrated in human 
subjects that fragmentation may become continuous within 
some aneurysms of patients with sustained ventricular tachy-
cardia, suggesting recording of the actual reentrant pathway. 
Whether electrophysiologic testing provides important in-
formation in patients with an akinetic segment or aneurysm 
alone in the absence of ventricular arrhythmias remains to 
be fully evaluated. 
Correlation with clinical configuration and rate of 
tachycardia. Although Buxton et aL (8) reported initiation 
of a ventricular tachycardia that resembled the spontaneous 
arrhythmia in 63% of their patients with non sustained ven-
tricular tachycardia, this was not the case in our patients. 
In fact, we found little correlation between the rate and 
configuration of the clinical nonsustained ventricular tachy-
cardia seen on Holter monitoring or telemetry and the in-
duced sustained or nonsustained ventricular tachycardia in 
the laboratory. This is not surprising because:· I ) the electro-
cardiographic lead system used to monitor patients during 
electrophysiologic study frequently differs from the lead 
configuration used to record Holter monitor or telemetry 
data, thereby making comparisons of configuration highly 
suspect; and 2) nonsustained ventricular tachycardia by Hol-
ter monitor is frequently variable in rate and configuration 
within the same run or between runs in patients with multiple 
episodes (25,26). Moreover, such comparisons hardly seem 
relevant to the 40% of patients in whom a sustained tachy-
arrhythmia was induced. We believe that, in contrast to 
patients with clinical episodes of recurrent sustained ven-
tricular tachycardia in whom the purpose of the laboratory 
protocol is to initiate the clinical arrhythmia and then test 
antiarrhythmic drug therapy, in patients with poor ventric-
ular function, nonsustained ventricular tachycardia is a marker 
for the abnormal electrophysiologic milieu necessary to al-
Iowa sustained tachyarrhythmia to develop. Thus, the goal 
of electrophysiologic testing in this group is simply to ex-
pose a latent abnormality, not reproduce a clinical arrhyth-
mia. Conceptually, this approach is similar to that of Rich-
ards et aL (9) in patients studied after acute myocardial 
infarction. 
Limitations and recommendations. Electrophysiologic 
testing has proved to be of value in the selection of antiar-
rhythmic drug and pacemaker or surgical therapy for patients 
with clinical episodes of sustained ventricular tachyarrhyth-
mias (18,27-31). However, in patients who are at high risk 
for sudden cardiac death but who have not yet developed a 
clinical sustained tachyarrhythmia, the role of electrophys-
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iologic testing in further defining risk remains to be estab-
lished (7,9,32-35). In patients after acute myocardial in-
farction, there is increasing evidence that such studies will 
enable the identification of those patients who will subse-
quently develop a life-threatening arrhythmia (9,32,33). 
In our study we have examined a second group at in-
creased risk for sudden cardiac death, namely, those patients 
with chronically poor left ventricular function and clinical 
episodes of non sustained ventricular tachycardia. However, 
we do not propose that it is yet sensible to assume that only 
those patients in whom sustained ventricular tachyarrhyth-
mias were induced should be treated aggressively and the 
other subgroups ignored. For the findings of this study (or 
any study that addresses the use of stimulation techniques 
to predict future arrhythmia development) to have full mean-
ing and a role for electrophysiologic testing in such patients 
to be secured, one of three approaches must be taken: 1) 
all patients must be randomized on the basis of the results 
of their initial study to different treatment methods and 
followed up for outcome; 2) all patients must be treated 
aggressively using electrophysiologic techniques after their 
baseline study and the results must be compared with those 
of a control group with nonsustained ventricular tachycardia 
and abnormal ventricular function receiving no therapy or 
"standard care;" or 3) all patients must be followed up 
while receiving no antiarrhythmic medications after their 
initial electrophysiologic evaluation. Although the last choice 
is clearly preferable scientifically, it is the most difficult 
option to pursue ethically and practically in the United States. 
Therefore, it is likely that the first and second options will 
help determine the true value of stimulation techniques in 
such high risk patients. 
We thank Richard Stones for technical assistance, Bernard Segal, MD for 
advice and support and Robyn Borlandoe for assistance in preparation of 
the manuscript. 
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